Codis Raises Growth Capital to Expand Commercial Manufacturing; Welcomes 1315 Capital

"The pharmaceutical industry increasingly needs spray-drying expertise in order to produce amorphous solid dispersions, drug substances, and functional excipients," said Matthew Reber, Partner at 1315 Capital. "We're proud to partner with Codis as the company expands its commercial manufacturing offerings in these markets." "The pharmaceutical industry increasingly needs spray-drying expertise in order to produce amorphous solid dispersions, drug substances, and functional excipients," said...

ST. LOUIS, 16/10/2025 (informazione.news - comunicati stampa - servizi)

Codis is a global CDMO specializing in commercial spray drying, amorphous solid dispersions, particle engineering, and finished dose manufacturing for the pharmaceutical, consumer health, nutraceutical, and OTC sectors. With more than 400,000 sq ft of cGMP facilities in St. Louis, MO , Seymour, IN and Haverhill, UK, Codis combines decades of regulatory expertise and manufacturing strength under one brand. Learn more at www.codis.com.

1315 Capital is a healthcare-focused private equity firm with more than $1 billion in assets under management. 1315 Capital specializes in growth equity, growth buyouts, and corporate carve-outs of commercial-stage healthcare companies, including healthcare services, pharma / medtech products, pharma / medtech outsourcing, and health & wellness businesses. Visit www.1315capital.com.

BroadOak Capital Partners is a boutique financial institution that provides direct investment and investment banking services to companies in the life science tools, diagnostics, and biopharma services sectors. BroadOak has led or participated in investments in more than 70 companies across the life sciences industry. For more information, visit www.broadoak.com.

Research Corporation Technologies (RCT) is a Tucson, Arizona–based investment and technology management company that provides funding and development support for life science and biomedical companies. RCT manages more than $500 million to advance technology and product development through flexible, long-term investments. Learn more at www.rctech.com.

Contact: Connor Halverson

Tel: +1 212 366 4455

Email: connor@thatsnice.com 

View original content:https://www.prnewswire.co.uk/news-releases/codis-raises-growth-capital-to-expand-commercial-manufacturing-welcomes-1315-capital-302586560.html